CTLA4 and neoplasm: Administration of SB-3CT or in combination with CTLA-4 blockade exhibited minimal effects on the body weight of the mice (Additional file 1: Fig. S6E-F), which further confirmed the limited toxicity associated with SB-3CT treatment in tumor-bearing mice.